Connect with us

News

Researchers develop smart earring to monitor skin temperature

The wearable has shown promise for monitoring signs of stress, eating, exercise and ovulation

Published

on

The Thermal Earring is a wireless wearable that continuously monitors a user’s earlobe temperature Source: Raymond Smith/University of Washington

University of Washington researchers have developed a smart wireless earring capable of continuously monitoring a user’s earlobe temperature.

In a study of six users, the Thermal Earring outperformed a smartwatch at sensing skin temperature during periods of rest.

The research, published in Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, also showed promise for monitoring signs of stress, eating, exercise and ovulation.

The smart earring prototype is about the size and weight of a small paperclip and has a 28-day battery life. A magnetic clip attaches one temperature sensor to a wearer’s ear, while another sensor dangles about an inch below it for estimating room temperature.

The earring can be personalised with fashion designs made of resin or with a gemstone, without negatively affecting its accuracy.

“I wear a smartwatch to track my personal health, but I’ve found that a lot of people think smartwatches are unfashionable or bulky and uncomfortable,” said co-lead author Qiuyue (Shirley) Xue, a UW doctoral student in the Paul G. Allen School of Computer Science & Engineering.

“I also like to wear earrings, so we started thinking about what unique things we can get from the earlobe. We found that sensing the skin temperature on the lobe, instead of a hand or wrist, was much more accurate. It also gave us the option to have part of the sensor dangle to separate ambient room temperature from skin temperature.”

Yujia (Nancy) Liu, co-lead author, who was a UW masters student in the electrical and computer engineering department when doing the research and is now at the University of California San Diego, said: “It’s a tricky balance.

“Typically, if you want power to last longer, you should have a bigger battery. But then you sacrifice size. Making it wireless also demands more energy.”

The team made the earring’s power consumption as efficient as possible, while also making space for a Bluetooth chip, a battery, two temperature sensors and an antenna.

Instead of pairing it with a device, which uses more power, the earring uses Bluetooth advertising mode — the transmissions a device broadcasts to show it can be paired. After reading and sending the temperature, it goes into deep sleep to save power.

Because continuous earlobe temperature has not been studied widely, the team also explored potential applications to guide future research. In five patients with fevers, the average earlobe temperature rose 10.62 degrees Fahrenheit (5.92 degrees Celsius) compared with the temperatures of 20 healthy patients, suggesting the earring’s potential for continuous fever monitoring.

Dr Mastafa Springston, co-author and clinical instructor at the department of emergency medicine in the UW School of Medicine, said: “In medicine we often monitor fevers to assess response to therapy to see, for instance, if an antibiotic is working on an infection.

“Longer term monitoring is a way to increase sensitivity of capturing fevers, since they can rise and fall throughout the day.”

While core body temperature generally stays relatively constant outside of fever, earlobe temperature varies more, presenting several novel uses for the Thermal Earring.

In small proof-of-concept tests, the earring detected temperature variations correlated with eating, exercising and experiencing stress.

When tested on six users at rest, the earring’s reading varied by 0.58 F (0.32 C) on average, placing it within the range of 0.28 C to 0.56 C necessary for ovulation and period tracking. A smartwatch varied by 0.72 C.

The temperature sensing earring is shown attached to a person’s ear. The portion touching the earlobe has a gemstone on it. Dangling a few centimeters below it is a pink flower made of resin.

The smart earring can be personalised with fashion designs made of resin without negatively affecting its accuracy. Source: Raymond Smith/University of Washington

“Current wearables like Apple Watch and Fitbit have temperature sensors, but they provide only an average temperature for the day, and their temperature readings from wrists and hands are too noisy to track ovulation,” Xue said.

“So we wanted to explore unique applications for the earring, especially applications that might be attractive to women and anyone who cares about fashion.”

While researchers found several promising potential applications for the earrings, their findings were preliminary, since the focus was on the range of potential uses. They need more data to train their models for each use case and more thorough testing before the device might be used by the public.

For future iterations of the device, Xue is working to integrate heart rate and activity monitoring. She is also interested in potentially powering the device from solar or kinetic energy from the earring swaying.

“Eventually, I want to develop a jewellery set for health monitoring,” she said.

“The earrings would sense activity and health metrics such as temperature and heart rate, while a necklace might serve as an electrocardiogram monitor for more effective heart health data.”

The device is not currently commercially available.

Fertility

Toxins and climate harms having ‘alarming’ effect on fertility, research warns

Published

on

Simultaneous exposure to toxic chemicals and climate-related heat may be worsening fertility harms across humans and wildlife, research suggests.

The review of scientific literature looks at how endocrine-disrupting chemicals, often found in plastic, together with climate-related effects such as heat stress, are each linked to lower fertility and fecundity, meaning the ability to reproduce, across species including humans, wildlife and invertebrates.

Though the reproductive harms of each issue in isolation are well studied, there is little research on what happens when living organisms are exposed to both.

“Together, the two issues are likely to pose a greater threat to fertility, and the additive effect is “alarming”, said Susanne Brander, a study lead author and courtesy faculty at Oregon State University.

“You’re not just getting exposed to one, but two, stressors at the same time that both may affect your fertility, and in turn the overall impact is going to be a bit worse,” Brander said.

The paper looked at 177 studies.

Shanna Swan, a co-author on the new paper, co-produced a 2017 study that found sperm levels among men in western countries had fallen by more than 50 per cent over four decades. Other research has suggested human fertility has been declining at a similar rate.

The University of Washington’s Institute for Health Metrics and Evaluation has previously said the world was approaching a “low-fertility future”, with more than three quarters of countries below replacement rate by 2050.

The new paper’s authors focused on the effects of endocrine-disrupting chemicals and substances, including microplastics, bisphenol, phthalates and PFAS.

These are thought to cause a range of serious reproductive problems, disrupt hormones and be a potential driver of falling fertility.

Brander said the harms linked to these chemicals are often similar across organisms, from invertebrates to humans.

Phthalates, for example, have been linked to altered sperm shape in invertebrates, spermatogenesis in rodents, meaning sperm production, and reduced sperm counts in humans.

PFAS are also thought to affect sperm quality, and both have been linked to hormone disruption.

The chemicals are widespread in consumer goods, so people are often regularly exposed.

Meanwhile, previous research has shown how rising temperatures, lower oxygen levels and heat stress, among other effects linked to climate change, may also worsen infertility.

Heat stress has been found to affect human hormones, and is linked to spermatogenesis in rodents and bulls.

Research shows temperature also plays a role in sex determination in fish, reptiles and amphibians.

The species has evolved to choose which sex it produces in part based on temperature, and the heating planet can “push it too far in one direction or the other, which overrides that evolutionary benefit”, Brander said.

Similarly, many endocrine disruptors may alter environmental sex determination.

The study set out some of the overlapping effects of chemical exposure and climate change across taxonomic groups, from invertebrates to humans.

In birds, for example, exposure to increased temperature, PFAS, organochlorines and pyrethroids may each individually cause abnormal sperm, increased fledgling mortality, abnormal testes and population decline.

“What happens if they’re exposed to more than one of those stressors at the same time? There has been little exploration of that question.

“Even if there have not been a lot of studies looking at these simultaneously, if you have two different factors that both cause the same adverse effect, then there’s a likelihood that they are going to be additive,” Brander said.

Katie Pelch, a senior scientist with the Natural Resources Defense Council nonprofit, who was not part of the study, said the authors had reviewed high-quality science.

She said she wanted to see more examples of the overlap in impacts, but agreed with the overall premise.

“It is likely [multiple stressors] would have an additive effect, at very least, even if they have different mechanisms of harm,” Pelch added.

The solution to the systemic problems would involve tackling climate change and reducing the use of toxic chemicals.

The study cites the global reduction in the use of DDT and PCBs achieved under the Stockholm Convention as an example of an effective measure, but Brander said much more is needed.

“There is enough evidence in both areas to act to reduce our impact on the planet,” she said.

Continue Reading

Pregnancy

Home blood pressure checks could lower heart risks for new mothers – study

Published

on

Home blood pressure checks after hypertensive pregnancy could cut the risk of heart attack, stroke and potentially early death, research suggests.

Women who regularly monitored their blood pressure in the weeks after giving birth, and had doctors tailor their medication if needed, had better functioning arteries nine months later than those who received routine care.

When the medication was adjusted to account for blood pressure changes, the women ended up with less stiff arteries, an effect researchers estimated could reduce the future risk of heart attack or stroke by 10 per cent.

Paul Leeson, professor of cardiovascular medicine who led the study, said the findings suggested that the weeks after birth provided a “powerful and often overlooked opportunity” to protect women’s future health.

“By simply monitoring blood pressure at home, new mothers with hypertensive pregnancies can protect their bodies from future damage,” he said.

High blood pressure, in the form of gestational hypertension or pre-eclampsia, where there are signs of organ damage, affects 5 to 10 per cent of pregnant women.

The condition can damage the mother’s organs and endanger the baby’s life.

Beyond the immediate threat to mother and baby, hypertension in pregnancy can raise the risk of long-term problems, with women three times more likely to develop high blood pressure and twice as likely to have heart disease later in life.

The Oxford team recruited 220 women who developed hypertension in pregnancy. All were on blood pressure medication but were due to reduce their dosage and eventually stop taking the drugs.

In the study, 108 women had standard care in which their medication was reduced based on a few blood pressure checks in the eight weeks after giving birth.

The remaining 112 women used a monitor to check their blood pressure at home each day.

They entered the readings into an app shared with doctors who, if needed, changed their medication day to day, with the aim of giving them better control of their blood pressure.

The new approach led to much better control of the women’s blood pressure, and in tests six to nine months later the women had less stiff arteries.

Stiff arteries are less effective at expanding and contracting, which can drive high blood pressure and ultimately the formation of clots that can block blood vessels and cause heart attacks and strokes.

Trials are now under way to find effective ways of rolling out blood pressure monitoring to women after hypertensive pregnancies. One option is for specialist NHS clinics to deliver the care.

Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation, which funded the work, said the results highlighted a crucial window after birth when paying close attention to blood pressure could help protect women’s heart health for years to come.

“We now look forward to seeing results from larger studies with longer follow-up to see how this might save women’s lives,” she said.

Continue Reading

Fertility

Researcher explores weight loss jab impact on PCOS

Published

on

Weight loss jabs are being studied to see if they could help women with polycystic ovary syndrome (PCOS)

The condition, which affects up to one in ten women, changes how the ovaries work and is linked to infertility and weight gain.

Dr Shagaf Bakour has won a £60,000 NHS research grant through Sandwell and West Birmingham NHS Trust to look at whether drugs such as Mounjaro and Ozempic might help.

“The research could lead to earlier support, better long-term health, and more joined-up care for a condition that affects many women but is still often overlooked,” she said.

Women with PCOS have higher levels of male hormones and can suffer from irregular periods and symptoms such as excess body or facial hair, the NHS said.

Associated weight gain can also lead to an increased risk of diabetes and heart problems.

Bakour, a gynaecologist and director of medical education at Aston Medical School, will work with a team to evaluate the effect of the weight loss medicines on metabolic and reproductive outcomes.

The drugs mimic a hormone called GLP-1, which suppresses appetite.

Bakour, alongside Dr Hoda Harb, a consultant obstetrician and gynaecologist at the NHS trust, will review existing evidence on their use and assess how they help patients with PCOS.

“The aim is to give women with PCOS evidence-informed, clearer treatment options and more consistent care,” she said.

“The project hopes to show whether these medicines can improve both general health and fertility health, while also helping local services develop clearer care pathways.

Prof Elizabeth Hughes, director of research and development at the NHS trust, said the effects of PCOS, including infertility, were “very emotive subjects”.

“We should be doing all we can within research and development to advance healthcare for women and to better help future generations with this condition,” she added.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.